NASDAQ · HYPMY
Healthcare · Drug Manufacturers - Specialty & Generic
$4.78
Up+$0.13 (+2.80%)
Updated Sep 23, 2026, 9:55 AM
SID Score
5.8/10
Composite research score
Smart Money
46/100
Neutral
Price performance
1M range · 0 trading sessions · Daily adjusted prices
HYPMY does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
The latest Smart Investors Daily articles mentioning HYPMY.
HYPMY research
Filterable reporting and market headlines.
Filters are reflected in the page URL for sharing and back-button support.
1 matching article.
Benzinga · Sep 21, 2026
Hypera (OTC:HYPMY) released second-quarter financial results and hosted an earnings call on Friday. Read the complete transcript below. This transcript is brought to you by Benzinga APIs. For real-time access to our
The latest Smart Investors Daily articles mentioning HYPMY.
